Page last updated: 2024-08-21

cyclopentane and Sarcoma, Kaposi

cyclopentane has been researched along with Sarcoma, Kaposi in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, PJ; Chen, LW; Chen, LY; Hung, CH; Shih, YJ; Wang, SS1
Baquero-PĂ©rez, B; Hughes, DJ; Jackson, BR; Whitehouse, A; Wood, JJ1

Other Studies

2 other study(ies) available for cyclopentane and Sarcoma, Kaposi

ArticleYear
Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
    Journal of virology, 2017, 10-01, Volume: 91, Issue:19

    Topics: Antigens, Viral; Butyric Acid; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; HEK293 Cells; Herpesvirus 8, Human; Humans; Immediate-Early Proteins; Immunoglobulin J Recombination Signal Sequence-Binding Protein; Nuclear Proteins; Promoter Regions, Genetic; Pyrimidines; Sarcoma, Kaposi; Tetradecanoylphorbol Acetate; Trans-Activators; Ubiquitin-Activating Enzymes; Virus Activation

2017
NEDDylation is essential for Kaposi's sarcoma-associated herpesvirus latency and lytic reactivation and represents a novel anti-KSHV target.
    PLoS pathogens, 2015, Volume: 11, Issue:3

    Topics: Cell Line, Tumor; Cyclopentanes; DNA Replication; DNA, Viral; Gene Expression Regulation, Viral; HEK293 Cells; Herpesvirus 8, Human; Humans; NEDD8 Protein; NF-kappa B; Pyrimidines; Sarcoma, Kaposi; Ubiquitins; Virus Activation

2015